// App-Quantinova.ai

2054 : REBECA: A phase I study of bevacizumab (BEV) and whole-brain radiation therapy (WBRT) for treatment of solid tumors brain metastases (BM), EudraCT: 2009-015977-11.

Researchers

Presenter

  • Christelle Levy

Principal Investigators

  • Djelila Allouache

  • Joelle Lacroix

  • Louis Gras

  • Marie-Pierre Sunyach

  • Iona Hrab

  • Julien Geffrelot

  • Katharina Gunzer

  • Jean-Marc Constans

  • Jean-Michel Grellard

  • Benedicte Clarisse

  • Marc-Andre Mahe

  • Marianne Leheurteur

  • Chantal Hanzen

  • Youlia M. Kirova

  • Francois Campana

  • Emilie Le Rhun

Medical Centers

  • University Hospital (CHU), Amiens, France

  • Institut de Cancerologie de l'Ouestsite Rene Gauducheau, Saint Herblain, France

  • Centre Leon Berard, Lyon, France

  • CRLCC Henri Becquerel, Rouen, France

  • Institut Curie, Paris Cedex, France

  • Centre Oscar Lambret, Lille, France

  • Centre Francois Baclesse, Caen, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Brain metastasis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bevacizumab

Outcome

  • Positive

Study Design

  • N/A

Phase

  • I

Study Id's

  • NCT01332929

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved